首页> 外国专利> 3-Amino-propionoyl 2-ethyl benzofuran(s) and salts - antithrombotics and blood platelet aggregation inhibitors, which inhibit factor XIII and fibrin formation

3-Amino-propionoyl 2-ethyl benzofuran(s) and salts - antithrombotics and blood platelet aggregation inhibitors, which inhibit factor XIII and fibrin formation

机译:3-氨基丙酰基2-乙基苯并呋喃和盐-抗血栓形成药和血小板凝集抑制剂,可抑制XIII因子和血纤蛋白的形成

摘要

3-R1R2N-CH2-CH2-CO 2-ethyl-benzofuran. (RX)n derivs. of formula (I) are new. In (I) NR1R2 is di(1-4C alkyl)amino(where the alkyl gps. are independently chosen), diallylamino, pyrrolidino, piperidino, perhydroazepino, morpholino, dimethylmorpholino, N-(1-4C alkyl)-piperazino, N-(2-hydroxyethyl)- piperazino, N-carbethoxypiperazino, N-benzyl-piperazino, N-methoxy-phenyl-piperazino or N-propynyl-piperazine; RX is an acceptable mineral or organic acid or an alkyl or aryl halide and n is 0, 1 or 2. Antithrombotics which are administered orally or parenterally in daily doses of 50-250 mg. Activity tests show (I) inhibit factor XIII and the formation of fibrin and are blood platelet aggregation inhibitors. In acute toxicity tests in mice, tested cpds. has oral LD50 values of 188-1400 mg/kg and I.V LD505 of 9.5-188.0mg/kg.
机译:3-R 1 R 2 N-CH 2 -CH 2 -CO 2-乙基-苯并呋喃。 (RX)n派生。式(I)的化学式是新的。在(I)中,NR 1 R 2是二(1-4C烷基)氨基(其中烷基gps是独立选择的),二烯丙基氨基,吡咯烷基,哌啶子基,全氢氮杂环庚烷,吗啉代,二甲基吗啉代,N-(1-4C烷基)-哌嗪子,N- (2-羟乙基)-哌嗪子基,N-乙氧基哌嗪子基,N-苄基-哌嗪子基,N-甲氧基-苯基-哌嗪子基或N-丙炔基-哌嗪; RX是可接受的无机酸或有机酸或烷基或芳基卤化物,n为0、1或2。抗血栓形成剂,以50-250 mg的每日口服或胃肠外给药。活性试验表明(Ⅰ)抑制因子XⅢ和纤维蛋白的形成,并且是血小板聚集抑制剂。在小鼠的急性毒性测试中,测试了cpds。口服LD50值为188-1400 mg / kg,IV LD505为9.5-188.0mg / kg。

著录项

  • 公开/公告号FR2488893A1

    专利类型

  • 公开/公告日1982-02-26

    原文格式PDF

  • 申请/专利权人 INNOTHERA;

    申请/专利号FR19800018212

  • 申请日1980-08-20

  • 分类号C07D307/81;A61K31/34;C07D405/06;

  • 国家 FR

  • 入库时间 2022-08-22 12:28:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号